Andrade GM, Ferreira R da S, Milki MV, Crispim SR de O. Capivasertib and fulvestrant, a new salvation for hormone receptor-positive breast cancer? A systematic review. MAST [Internet]. 2026 Mar. 5 [cited 2026 May 1];34(suppl. 1). Available from: https://mastology.org/journal/article/view/1456